Clinical uses of benzodiazepines. Focus on: benzodiazepines and anxiety disorders

被引:0
|
作者
Bossini, L. [1 ]
Borghini, E. [1 ]
Fagiolini, A. [1 ]
机构
[1] Univ Siena, Dipartimento Med Mol Sviluppo, Sez Psichiatria, Siena, Italy
来源
JOURNAL OF PSYCHOPATHOLOGY | 2013年 / 19卷 / 03期
关键词
Benzodiazepines; Anxiety; Anxiety disorders;
D O I
暂无
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Benzodiazepines (BDZs) are usually safe and well-tolerated medications, which may be effectively prescribed in Anxiety Disorders and several other conditions requiring an anxiolytic and hypnotic therapeutic effect. Most often, BDZs should be considered as a complementary, rather than alternative, treatment to antidepressants such as SSRIs and SNRIs or to psychotherapies. Nonetheless, BDZs my be very useful tools both in the acute treatment phase, due to their ability to control anxious symptoms before the antidepressants start working, and in the continuation-maintenance treatment phase, as augmenting agents. BDZ have proven very effective in panic disorder, generalized anxiety and, even if to a lower degree, in social phobia. BDZ role in obsessive compulsive disorder and post traumatic stress disorder is not as strong but these medications may be useful for several patients with those diseases. BDZ are not devoid of side effects and risks such as tolerance and dependence. However, those risks may be reduced when BDZ are not used at high doses for long periods of time, when the choice of the specific compound is driven by an accurate evaluation of the specific pharmacokinetic properties and when patients at high risk of dependence are not prescribed these compounds, especially at high doses and for long periods of time.
引用
收藏
页码:272 / 286
页数:15
相关论文
共 50 条
  • [1] Benzodiazepines in Anxiety Disorders
    Fava, Giovanni A.
    Balon, Richard
    Rickels, Karl
    JAMA PSYCHIATRY, 2015, 72 (07) : 733 - 734
  • [2] CLINICAL USES OF BENZODIAZEPINES
    HOLLISTER, LE
    MULLEROERLINGHAUSEN, B
    RICKELS, K
    SHADER, RI
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1993, 13 (06) : S1 - S169
  • [3] Therapeutic applications of immunosuppressive benzodiazepines.
    Glick, GD
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 219 : U137 - U138
  • [4] Role of Benzodiazepines in Anxiety Disorders
    Balon, Richard
    Starcevic, Vladan
    ANXIETY DISORDERS: RETHINKING AND UNDERSTANDING RECENT DISCOVERIES, 2020, 1191 : 367 - 388
  • [5] USE OF BENZODIAZEPINES IN ANXIETY DISORDERS
    GROSS, HS
    NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (20): : 1501 - 1501
  • [6] The Role of Benzodiazepines in the Treatment of Anxiety Disorders: A Clinical Review
    Macaluso, Matthew
    Kalia, Rachna
    Ali, Faryal
    Khan, Ahsan Y.
    PSYCHIATRIC ANNALS, 2010, 40 (12) : 605 - 610
  • [7] Anxiety and benzodiazepines. A Delphi method-based survey of knowledge on their pharmacology and clinical use
    Vampini, C.
    Gallelli, L.
    JOURNAL OF PSYCHOPATHOLOGY-GIORNALE DI PSICOPATOLOGIA, 2014, 20 (03): : 322 - 340
  • [8] Molecular imprinting for enantiomeric separations of benzodiazepines.
    Hart, BR
    Rush, DJ
    Shea, KJ
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 218 : U437 - U437
  • [9] The use of benzodiazepines in anxiety and other disorders
    Argyropoulos, SV
    Nutt, DJ
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 1999, 9 : 407 - 412
  • [10] Withdrawing Benzodiazepines in Patients With Anxiety Disorders
    Malcolm Lader
    Andri Kyriacou
    Current Psychiatry Reports, 2016, 18